Eden Research plc (LON:EDEN – Get Free Report)’s stock price traded up 16.2% during mid-day trading on Tuesday after an insider bought additional shares in the company. The stock traded as high as GBX 4.18 ($0.05) and last traded at GBX 4.18 ($0.05). 11,679,602 shares changed hands during trading, an increase of 643% from the average session volume of 1,571,173 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey acquired 540,540 shares of the business’s stock in a transaction on Tuesday, January 28th. The shares were acquired at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($26,902.58).
Eden Research Price Performance
The firm has a market cap of £19.73 million, a P/E ratio of -200.00 and a beta of 0.92. The company has a debt-to-equity ratio of 1.25, a current ratio of 3.80 and a quick ratio of 2.42. The firm’s 50 day moving average is GBX 3.88 and its 200 day moving average is GBX 4.01.
Eden Research Company Profile
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
Read More
- Five stocks we like better than Eden Research
- Using the MarketBeat Dividend Yield Calculator
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- ESG Stocks, What Investors Should Know
- What Does the Future Hold for Eli Lilly?
- Conference Calls and Individual Investors
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.
